Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Reversal of Ventricular Remodeling With Toprol-XL

ClinicalTrials.gov ID: NCT00038077

Public ClinicalTrials.gov record NCT00038077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00038077
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Seloken ZOK/Toprol-XL Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2001
Primary completion
Aug 31, 2003
Completion
Aug 31, 2003
Last update posted
Nov 18, 2010

2001 – 2003

United States locations

U.S. sites
44
U.S. states
25
U.S. cities
44
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Mobile Alabama
Not listed Little Rock Arkansas
Not listed Los Angeles California
Not listed Northridge California
Not listed Redondo Beach California
Not listed Riverside California
Research Site Farmington Connecticut
Not listed Clearwater Florida
Not listed Melbourne Florida
Not listed Vero Beach Florida
Not listed Augusta Georgia
Not listed Indianapolis Indiana
Not listed Jeffersonville Indiana
Not listed Edgewood Kentucky
Not listed New Orleans Louisiana
Not listed Shreveport Louisiana
Not listed Auburn Maine
Not listed Baltimore Maryland
Not listed Salisbury Maryland
Not listed Boston Massachusetts
Not listed Saint Charles Missouri
Not listed St Louis Missouri
Not listed Omaha Nebraska
Not listed Albuquerque New Mexico
Not listed Buffalo New York
Not listed East Syracuse New York
Not listed New York New York
Not listed Rochester New York
Not listed The Bronx New York
Not listed Williamsville New York
Not listed Burlington North Carolina
Not listed Columbus Ohio
Not listed Oklahoma City Oklahoma
Not listed Flourtown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Pittsburgh Pennsylvania
Not listed Lincoln Rhode Island
Not listed Wakefield Rhode Island
Not listed Tyler Texas
Not listed Salt Lake City Utah
Not listed Chesapeake Virginia
Not listed Roanoke Virginia
Not listed Green Bay Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00038077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00038077 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →